Lily Pao
Senior Director, Biologics Discovery,
Johnson & Johnson
Lily Pao, Ph.D. is Senior Director of Biologics Discovery at Johnson & Johnson Innovative Medicine, where she leads efforts to advance next-generation immune cell engagers for cancer and immune disorders. Previously, she headed Sanofi’s Immuno-Oncology Cluster, driving the discovery of multi-specific biologics and contributing to several clinical candidates. With deep expertise in biologics, immune modulation, and translational strategy, Lily has led cross-functional teams, shaped portfolio strategy, and fostered external collaborations. She is passionate about scientific innovation, mentoring, and building high-performing teams to accelerate the development of transformative therapies for patients


